MEK Inhibitor PD-325901 To Treat Advanced Non-Small Cell Lung Cancer

NCT00174369 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

34

Enrollment

INDUSTRY

Sponsor class

Stopped Terminated \[See Detailed Description for Termination Reason.\]

Conditions

Carcinoma, Non-Small-Cell Lung

Interventions

DRUG: PD-0325901

Sponsor

Pfizer